MedTrace Logo

Dry Dynamic Cupping vs Instrument-Assisted Soft Tissue Mobilization for Chronic Myofascial Low Back Pain

NCT07685340 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-07-06

No results posted yet for this study

Summary

This study aims to compare the effects of Dry Dynamic Cupping and Instrument-Assisted Soft Tissue Mobilization (IASTM) in patients with chronic myofascial low back pain. The interventions will be evaluated for their effectiveness in reducing pain, improving functional disability, and enhancing quality of life. The findings may help identify a more effective treatment approach for managing chronic myofascial low back pain.

Conditions

  • Chronic Myofascial Low Back Pain

Interventions

OTHER

Instrument Assisted Soft Tissue Mobilization (IASTM)

Participants in this group will receive Instrument-Assisted Soft Tissue Mobilization (IASTM). The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

OTHER

dry cupping

Participants in this group will receive Dry Dynamic Cupping therapy. The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

Sponsors & Collaborators

  • Ibadat International University, Islamabad

    lead OTHER

Principal Investigators

  • MUHAMMAD ASHAR RAFI, DPT, MS-NMPT · IBADAT INTERNATIONAL UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-08-15
Completion
2026-09-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07685340 on ClinicalTrials.gov